Literature DB >> 3546307

Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates.

C M Kam, B J McRae, J W Harper, M A Niemann, J E Volanakis, J C Powers.   

Abstract

The specificity and reactivity of complement serine proteases D, B, Bb, C2, and C2a were determined using a series of peptide thioester substrates. The rates of thioester hydrolysis were measured using assay mixtures containing the thiol reagent 4,4'-dithiodipyridine at pH 7.5. Each substrate contained a P1 arginine residue, and the effect of various groups and amino acids in the P2, P3, P4, and P5 positions was determined using kcat/Km values to compare reactivities. Among peptide thioesters corresponding to the activation site sequence in B, dipeptide thioesters containing a P2 lysine residue were the best substrates for D. Extending the chain to include a P3 or P4 amino acid resulted in loss of activity, and neither the tripeptide nor the tetrapeptide containing the cleavage sequence of B was hydrolyzed. Overall, D cleaved fewer substrates and was 2-3 orders of magnitude less reactive than C1s against some thioester substrates. C2 and fragment C2a had comparable reactivities and hydrolyzed peptides containing Leu-Ala-Arg and Leu-Gly-Arg, which have the same sequence as the cleavage sites of C3 and C5, respectively. The best substrates for C2 and C2a were Z-Gly-Leu-Ala-Arg-SBzl and Z-Leu-Gly-Leu-Ala-Arg-SBzl, respectively, where Bzl is benzyl. B was the least reactive among these complement enzymes. The best substrate for B was Z-Lys-Arg-SBzl with a kcat/Km value of 1370 M-1 s-1. The catalytic fragment of B, Bb, had higher activity toward these peptide thioester substrates. The best substrate for Bb was Z-Gly-Leu-Ala-Arg-SBzl with a kcat/Km similar to C2a and 10 times higher than the value for B. Both C2a and Bb were considerably more reactive against C3-like than C5-like substrates. Bovine trypsin hydrolyzed thioester substrates with kcat/Km approximately 10(3) higher than the complement enzymes. These thioester substrates for D, B, and C2 should be quite useful in kinetic and active site studies of the purified enzymes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3546307

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  New structural motifs on the chymotrypsin fold and their potential roles in complement factor B.

Authors:  H Jing; Y Xu; M Carson; D Moore; K J Macon; J E Volanakis; S V Narayana
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

2.  Mutants of complement component C3 cleaved by the C4-specific C1-s protease.

Authors:  P Mathias; C J Carrillo; N E Zepf; N R Cooper; R T Ogata
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

3.  Effect of N-methylation on the modulation by synthetic peptides of the activity of the complement-factor-B-derived serine proteinase CVFBb.

Authors:  A Berkovich; M C O'Keefe; P Hensley; L Caporale
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

Review 4.  Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.

Authors:  A R Khan; M N James
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

5.  Structures of C3b in complex with factors B and D give insight into complement convertase formation.

Authors:  Federico Forneris; Daniel Ricklin; Jin Wu; Apostolia Tzekou; Rachel S Wallace; John D Lambris; Piet Gros
Journal:  Science       Date:  2010-12-24       Impact factor: 47.728

6.  A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins.

Authors:  Brandon L Garcia; Brady J Summers; Kasra X Ramyar; Apostolia Tzekou; Zhuoer Lin; Daniel Ricklin; John D Lambris; John H Laity; Brian V Geisbrecht
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

7.  Small-molecule factor D inhibitors targeting the alternative complement pathway.

Authors:  Jürgen Maibaum; Sha-Mei Liao; Anna Vulpetti; Nils Ostermann; Stefan Randl; Simon Rüdisser; Edwige Lorthiois; Paul Erbel; Bernd Kinzel; Fabrice A Kolb; Samuel Barbieri; Julia Wagner; Corinne Durand; Kamal Fettis; Solene Dussauge; Nicola Hughes; Omar Delgado; Ulrich Hommel; Ty Gould; Aengus Mac Sweeney; Bernd Gerhartz; Frederic Cumin; Stefanie Flohr; Anna Schubart; Bruce Jaffee; Richard Harrison; Antonio Maria Risitano; Jörg Eder; Karen Anderson
Journal:  Nat Chem Biol       Date:  2016-10-24       Impact factor: 15.040

8.  Production and functional activity of a recombinant von Willebrand factor-A domain from human complement factor B.

Authors:  S C Williams; J Hinshelwood; S J Perkins; R B Sim
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

9.  Purification and partial characterization of rat factor D.

Authors:  B C Baker; C J Campbell; C J Grinham; G Turcatti
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

10.  Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.

Authors:  Suzan H M Rooijakkers; Jin Wu; Maartje Ruyken; Robert van Domselaar; Karel L Planken; Apostolia Tzekou; Daniel Ricklin; John D Lambris; Bert J C Janssen; Jos A G van Strijp; Piet Gros
Journal:  Nat Immunol       Date:  2009-06-07       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.